drugset / Trial / NCT01943006

Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis

NCT01943006

Phase 3 Completed 144 enrolled Medinova AG
RandomizedParallel-groupTriple-blindPrevention

Summary

Patients receiving nutritional emulsion for at least 3 days will be treated with Hirudoid cream or placebo cream to prevent and treat phlebitis caused by the infusion. The treatment is continued after the end of infusion for at least 7 days. Number of patients developing superficial phlebitis and duration of phlebitis will be recorded.

Timeline

Start
2015-05
Primary completion
2017-02
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject MUCOPOLYSACCHARIDE POLYSULFATE Small molecule 0.3 %

Indications